Howard Hochster, MD, shares his perspective on the outcomes of the PRODIGY7 study in metastatic colorectal cancer patients using heated single agent oxaliplatin after surgery at the 2018 Annual Meeting.
Â
Â
Â
Â
metastatic colorectal cancer patients, prodigy7 study, mcrc, perspective on the outcomes